Results 241 to 250 of about 102,886 (302)

Low-concentration bimatoprost 0.01% and timolol 0.1% eye gel versus bimatoprost 0.03% and timolol 0.5% eye drops in open-angle glaucoma or ocular hypertension: a phase III randomised study. [PDF]

Br J Ophthalmol
Cordeiro MF, Oddone F, Mermeklieva EA, Rokicki DM, Nisslé S, Gościniewicz P, Stalmans I.   +6 more
europepmc   +1 more source

Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension. [PDF]

Pharmaceuticals (Basel)
Matamoros JA, Rubio-Casado S, Fernández-Albarral JA, Martínez-López MA, Ramírez AI, Salobrar-García E, Marco EM, Paleo-García V, de Hoz R, López-Cuenca I, Elvira-Hurtado L, Sánchez-Puebla L, Ramírez JM, López-Gallardo M, Salazar JJ.   +14 more
europepmc   +1 more source

Transient ocular hypertension remodels astrocytes through S100B. [PDF]

PLoS One
Huang W, Matsushita K, Kawashima R, Hara S, Yasukura Y, Yamaguchi K, Usui S, Baba K, Quantock AJ, Nishida K.   +9 more
europepmc   +1 more source

Management of ocular hypertension following intravitreal dexamethasone implant (ozurdex). [PDF]

Am J Ophthalmol Case Rep
Xiao J, Qiu M.
europepmc   +1 more source

Secondary Ocular Hypertension with Exophthalmos as the First Presentation of Endogenous Cushing's Syndrome. [PDF]

Case Rep Ophthalmol
Threetong T, Leelawongs S.
europepmc   +1 more source

Pharmacogenomics of steroid-induced ocular hypertension: relationship to high-tension glaucomas and new pathophysiologic insight

Song Z, Pany S, Guo S, Mazumder AG, Itakura T, Huang J, Magarychoff E, Gurinovich A, Benchek PH, Stamer WD, Price FW, Willoughby CE, Senthilkumari S, George RJ, Chitipothu S, Lass JH, Iyengar SK, Schwartz SG, Griswold AJ, Sebastiani P, Price MO, Fini ME.   +21 more
europepmc   +1 more source

Selective Laser Trabeculoplasty After Medical Treatment for Glaucoma or Ocular Hypertension.

JAMA Ophthalmol
Konstantakopoulou E, Gazzard G, Garway-Heath D, Adeleke M, Ambler G, Vickerstaff V, Bunce C, Nathwani N, Barton K, LiGHT Trial Study Group.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

AUTONOMIC NEUROPATHY IN OCULAR HYPERTENSION

Lancet, The, 1985
By means of a series of cardiovascular autonomic function tests, systemic parasympathetic neuropathy was demonstrated in 41.8% of 189 patients with ocular hypertension and in 2.6% of 76 controls. Parasympathetic neuropathy was significantly more common in patients with narrow-angle hypertension than in those with wide-angle hypertension.
C V Clark, R Mapstone
exaly   +3 more sources